Genetic testing heralds next generation of diagnostics in NHS
Motherlabs member GENinCode has developed a new DNA test that looks at genetics as a risk factor for heart disease, heralding a new era of diagnostics in the NHS.
Matthew Walls, chief executive of GENinCode, said looking at information from the tests allows doctors to “provide a risk assessment” on the likelihood of a patient having a heart attack.
“That’s quite a big step change in the way that risk assessment and diagnosis of patients will be delivered moving forward.”
You can read the full article in the independent here.
GENinCode is based in Motherlabs our science and technology accelerator space in West London. You can find out more about Motherlabs here.
